SPOTLIGHT -
ARVO 2024: AI may open new frontiers in vision research
Claris Bio's journey toward treating neurotrophic keratitis
Study reveals lower vision specific quality of life in children with cortical/cerebral visual impairment
(EyePod) From idea to impact: Navigating ophthalmic innovation
ARVO 2024: Researchers drive innovation in retinal research
ARVO 2024: Study validates ChatGPT 4.0 as potential uveitis patient resource